Rituximab in glomerular diseases: Indications, long-term use, complications and research gaps
{{output}}
Rituximab (RTX) is a monoclonal antibody targeted against the B-cell surface antigen CD20 that plays a significant role in the treatment of glomerular diseases. It is approved for the induction and maintenance of remission of anti-neutrophil cytoplasmic antibo... ...
